Author

James B. Yu

Institutions: Dartmouth–Hitchcock Medical Center, Yale Cancer Center, Yale University

Observed institutions: Dartmouth–Hitchcock Medical Center, Yale Cancer Center, Yale University

ORCID: 0000-0002-3119-3226

Observed ORCID: 0000-0002-3119-3226

OpenAlex ID: A5127857501

A randomized phase 2 study of enhanced AR blockade with enzalutamide in high-risk patients with biochemical relapse undergoing salvage radiation: Final results from RTOG 3506 (STEEL).

2026 · Edwin Melencio Posadas, Hiram Alberto Gay, et al. · Journal of Clinical Oncology · 1

County-Level Structural Racism Indices and Racial Disparities in Lung Cancer Care

2026 · Jacquelyne J. Gaddy, Do H. Lee, et al. · JAMA Network Open

In Reply to Shaffer et al

2026 · James B. Yu, David Grew, et al. · Practical Radiation Oncology

Early-Stage Lung Cancer Treatment Disparities by Race Among Medicare Beneficiaries

2026 · Olivia F. Lynch, Do H. Lee, et al. · JAMA Network Open

SWOG 2427: Single arm phase II study of bladder preservation with immunoradiotherapy after a clinically meaningful response to neoadjuvant therapy in patients with muscle invasive bladder cancer (BRIGHT).

2026 · Leslie K. Ballas, Samuel Callis, et al. · Journal of Clinical Oncology

Works count: 5

Citation count: 1

H-index: 1

I10-index: